Abstract
The pleiotropic nature of the clinical phenotypes of patients with ataxia-telangiectasia (A-T)-which encompass cerebellar degeneration (leading to ataxia), gonadal atrophy, and cancer predisposition-suggests multiple functions of the gene responsible for the disease. The ataxia-telangiectasia mutated gene product (ATM), whose loss of function is responsible for ataxia-telangiectasia, is a protein kinase that interacts with several substrates and is implicated in mitogenic signal transduction, chromosome condensation, meiotic recombination, cell-cycle control and telomere maintenance. This review focuses on the critical roles that ATM appears to play in cell-cycle checkpoints, DNA repair, telomere metabolism and oxidative stress, indicating how defects in these processes might lead to ataxia-telangiectasia.
Original language | English (US) |
---|---|
Journal | Expert Reviews in Molecular Medicine |
Volume | 5 |
Issue number | 16 |
DOIs | |
State | Published - Jun 20 2003 |
Keywords
- A-T
- ataxia telangiectasia
- ATM
- cancer
- DNA damage
- neurodegeneration
- signal transduction
ASJC Scopus subject areas
- Molecular Biology
- Molecular Medicine
- General Biochemistry, Genetics and Molecular Biology
- General Medicine